Delivery Order SPE2DB20D7059-SPE2DB26FGRA3
- Not listed
- The Defense Logistics Agency awarded a $2,605.16 firm fixed price delivery order to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 (6M-11Y) syringes at 0.25ml on October 29, 2025, with completion scheduled for November 20, 2025. This is a non-set-aside competitive award for pediatric COVID-19 vaccine delivery to support federal immunization programs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor...
- The Defense Logistics Agency awarded a Delivery Order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of SPIKEVAX 2025-26 pediatric vaccine (6 months to 11 years) in 0.25 milliliter syringes. Valued at $2,390.04 with firm fixed pricing, this non-set-aside competitive award is scheduled for completion by November 20, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, fulfills this order as the place of performance location, leveraging its established role...
- The Defense Logistics Agency awarded a delivery order valued at $6,088.75 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 (6M-11Y) syringes at 0.25mL on September 24, 2025, with completion scheduled for September 25, 2025. This competitively awarded, firm fixed-price delivery order was placed under no set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The product supplied—a pediatric COVID-19 vaccine formulation for children ages 6 months to 11...
- The Defense Logistics Agency awarded a delivery order valued at $1,953.84 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 (6M-11Y) syringes at 0.25ML on September 26, 2025, with a completion date of September 29, 2025. This firm fixed price delivery order represents a pediatric vaccine supply for children ages 6 months to 11 years and carries no set-aside designation, indicating it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,579.20 for Spikevax 2025-26 vaccine (12 years and up) in 0.5ML syringes, with a completion date of November 21, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,302.58 to supply Spikevax 2025-26 vaccine (6M-11Y) in 0.25ML syringes, with an ultimate completion date of October 20, 2025. This competitively awarded, firm fixed-price delivery order was issued under no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 pediatric vaccine (6 months to 11 years) in a 0.25 mL syringe formulation, with a ceiling value of $3,783.18. This firm fixed-price delivery order, awarded on October 24, 2025, with ultimate completion by November 17, 2025, carries no set-aside designation and represents a competitive award. The contract is performed at AmerisourceBergen's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 (6M-11Y) SYR 0.25ML vaccine product valued at $6,305.30, with an ultimate completion date of November 20, 2025. This non-set-aside, competitively awarded contract is a firm fixed price delivery order executed under AmerisourceBergen's larger prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The contract...
- The Defense Logistics Agency awarded a delivery order valued at $6,512.80 to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Spikevax 2025-26 vaccine (6 months to 11 years) in 0.25 mL syringes. This is a firm fixed price delivery order with no set-aside designation, competitively awarded and scheduled for completion by September 26, 2025. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $2,605.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for Spikevax 2025-26 vaccine syringes (6 months to 11 years, 0.25ML) to be delivered to the company's facility in Conshohocken, Pennsylvania by September 26, 2025. This non-competitive delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB26FGRA3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,195.01 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 (6M-11Y) Syringe 0.25ML, a pediatric COVID-19 vaccine formulation. This firm fixed price delivery order, awarded on October 29, 2025, with an ultimate completion date of November 20, 2025, represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor supporting military and veteran healthcare systems. The company's role as a prime vendor under the DLA Troop Support Medical IDC enables it to supply pharmaceuticals, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for pediatric COVID-19 vaccine syringes reflects the company's ongoing role in supporting federal immunization and public health initiatives across the defense and military healthcare infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 10/29/25 |